Overview

Study of Pharmacotherapy of Psychotic Depression

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

This study will determine the effectiveness of combining selective serotonin reuptake inhibitors (SSRIs) with antipsychotic medications in the treatment of psychotic depression.

Phase:

Phase 3

Details

Lead Sponsor:

Weill Medical College of Cornell University

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Antipsychotic Agents
Olanzapine
Serotonin Uptake Inhibitors
Sertraline